Evidence map›Paper›PMID 35250971›Full record

ArticleFrontiers in immunology2022

Deletion of

Betsabel Chicana, Nastaran Abbasizadeh, Christian Burns, Hanna Taglinao, Joel A Spencer, Jennifer O Manilay

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Deletion ofFrontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Betsabel ChicanaDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced, Merced, CA, United States.
Nastaran AbbasizadehQuantitative and Systems Biology Graduate Program, University of California, Merced, Merced, CA, United States.
Christian BurnsQuantitative and Systems Biology Graduate Program, University of California, Merced, Merced, CA, United States.
Hanna TaglinaoDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced, Merced, CA, United States.
Joel A SpencerQuantitative and Systems Biology Graduate Program, University of California, Merced, Merced, CA, United States.
Jennifer O ManilayDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced, Merced, CA, United States.
University of California, Merced · US

Funding

Anatomical and Molecular Investigation of Microenvironments that Influence B LymphocytesR15AI154245 · NIAID · UNIVERSITY OF CALIFORNIA, MERCED · PI MANILAY, JENNIFER O, SPENCER, JOEL A. · 2020 to 2020
$450k
Deletion of von-Hippel Lindau gene in Dmp1 expressing cells impairs hematopoiesisF31AI154815 · NIAID · UNIVERSITY OF CALIFORNIA, MERCED · PI CHICANA, BETSABEL · 2021 to 2021
$37k
NIAID NIH HHS F31 AI154815NIAID NIH HHS R15 AI154245
6 · The paper itself

Abstract

The contributions of skeletal cells to the processes of B cell development in the bone marrow (BM) have not been completely described. The von-Hippel Lindau protein (VHL) plays a key role in cellular responses to hypoxia. Previous work showed that

Indexed as

LymphopoiesisMesenchymal Stem CellsAnimalsB-LymphocytesBone MarrowExtracellular Matrix ProteinsHypoxiaMiceVon Hippel-Lindau Tumor Suppressor ProteinDmp1 protein, mouseExtracellular Matrix ProteinsVHL protein, mouseVon Hippel-Lindau Tumor Suppressor ProteinB lymphocytesbone marrow nicheshypoxiamicroenvironmentosteoimmunology

Identifiers

PMID35250971
PMCPMC8889104
OpenAlexW4220793376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.